Auddia receives Nasdaq minimum bid price deficiency notice; 180-day cure period starts

AUDDIA INC.

Received Nasdaq notice on Oct 16, 2024 for failing $1.00 minimum bid price over 30 consecutive business days (Sept 4–Oct 15, 2024).
Has 180 calendar days until April 14, 2025 to regain compliance by closing at $1.00+ for 10 consecutive business days.
If not cured, may be eligible for additional 180 days if other listing requirements met and reverse stock split considered.
Company intends to monitor bid price and evaluate options; notice does not affect business operations or SEC reporting.
Continued listing on Nasdaq Capital Market is not immediately affected; delisting possible if non-compliance persists.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.